Coronavirus vaccine from recovered patients

Israel’s Kamada is developing a treatment against the coronavirus derived from the blood-plasma of patients who have recovered from the disease and are in convalescence. Kamada says that the plasma is likely to contain antibodies that can be the basis for a vaccine.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *